These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 17671282

  • 1. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
    Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ.
    Am J Psychiatry; 2007 Aug; 164(8):1198-205. PubMed ID: 17671282
    [Abstract] [Full Text] [Related]

  • 2. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
    Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ.
    Am J Psychiatry; 2007 Jun; 164(6):884-91. PubMed ID: 17541047
    [Abstract] [Full Text] [Related]

  • 3. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.
    Morrato EH, Libby AM, Orton HD, Degruy FV, Brent DA, Allen R, Valuck RJ.
    Am J Psychiatry; 2008 Jan; 165(1):42-50. PubMed ID: 17986680
    [Abstract] [Full Text] [Related]

  • 4. Persisting decline in depression treatment after FDA warnings.
    Libby AM, Orton HD, Valuck RJ.
    Arch Gen Psychiatry; 2009 Jun; 66(6):633-9. PubMed ID: 19487628
    [Abstract] [Full Text] [Related]

  • 5. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [Abstract] [Full Text] [Related]

  • 6. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
    Cheung A, Sacks D, Dewa CS, Pong J, Levitt A.
    J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
    [Abstract] [Full Text] [Related]

  • 7. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ.
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [Abstract] [Full Text] [Related]

  • 8. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
    Valluri S, Zito JM, Safer DJ, Zuckerman IH, Mullins CD, Korelitz JJ.
    Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
    [Abstract] [Full Text] [Related]

  • 9. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
    Rihmer Z, Akiskal H.
    J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
    [Abstract] [Full Text] [Related]

  • 10. Antidepressants use in pediatric populations.
    Gören JL.
    Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
    [Abstract] [Full Text] [Related]

  • 11. The black box warning: decreased prescriptions and increased youth suicide?
    Jureidini J.
    Am J Psychiatry; 2007 Dec; 164(12):1907; author reply 1908-10. PubMed ID: 18056248
    [No Abstract] [Full Text] [Related]

  • 12. Pediatric oncologists' practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: a multi-site study.
    Phipps S, Buckholdt KE, Fernandez L, Wiener L, Kupst MJ, Madan-Swain A, Mullins L, Robert R, Sahler OJ, Vincent N, Noll RB.
    Pediatr Blood Cancer; 2012 Feb; 58(2):210-5. PubMed ID: 21284076
    [Abstract] [Full Text] [Related]

  • 13. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.
    Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Mann JJ.
    Am J Psychiatry; 2007 Jul; 164(7):1044-9. PubMed ID: 17606656
    [Abstract] [Full Text] [Related]

  • 14. National trends in prescribing antidepressants before and after an FDA advisory on suicidality risk in youths.
    Chen SY, Toh S.
    Psychiatr Serv; 2011 Jul; 62(7):727-33. PubMed ID: 21724784
    [Abstract] [Full Text] [Related]

  • 15. The relationship between antidepressant medication use and rate of suicide.
    Gibbons RD, Hur K, Bhaumik DK, Mann JJ.
    Arch Gen Psychiatry; 2005 Feb; 62(2):165-72. PubMed ID: 15699293
    [Abstract] [Full Text] [Related]

  • 16. SSRI prescriptions and the rate of suicide.
    Olfson M, Shaffer D.
    Am J Psychiatry; 2007 Dec; 164(12):1907-8; author reply 1908-10. PubMed ID: 18056247
    [No Abstract] [Full Text] [Related]

  • 17. [The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the «black box» warning].
    Plener PL, Fegert JM, Kölch MG.
    Z Kinder Jugendpsychiatr Psychother; 2012 Nov; 40(6):365-71. PubMed ID: 23109125
    [Abstract] [Full Text] [Related]

  • 18. Withdrawal of attention rather than pharmacological treatment affects suicide rates in depressed children and adolescents.
    Wohlfarth T, Boer F, van den Brink W.
    Am J Psychiatry; 2007 Dec; 164(12):1908; author reply 1908-10. PubMed ID: 18056249
    [No Abstract] [Full Text] [Related]

  • 19. Changes in antidepressant medications prescribing trends in children and adolescents in Hawai'i following the FDA black box warning.
    Hassanin H, Harbi A, Saif A, Davis J, Easa D, Harrigan R.
    Hawaii Med J; 2010 Jan; 69(1):17-9. PubMed ID: 20222492
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.